Divine Aleru

Divine Aleru, Microbiome Medicine Research Coordinator

About

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

Recent Posts

2025-09-10

Introducing the ArsR-Regulated Arsenic Stimulon

This study explored the complex regulatory roles of ArsR proteins in Agrobacterium tumefaciens 5A, showing they influence a broad range of cellular functions, including arsenic resistance, metabolism, and iron homeostasis.

2025-09-10

Distribution of Arsenic Resistance Genes in Prokaryotes

This review outlines the diversity, evolution, and distribution of arsenic resistance genes in prokaryotes, emphasizing their central role in the environmental microbiome, biogeochemical cycling, and potential clinical implications through gene transfer and resistance in pathogens.

2025-09-10

The Human Gut Microbiome’s Influence on Arsenic Toxicity

The human gut microbiome and arsenic toxicity are tightly linked: microbes change arsenic speciation and dose, while arsenic reshapes gut ecology, altering risk. Clinicians should integrate microbiome status, nutrition, antibiotics history, and speciation into assessment and management.

2025-09-06

The Promise of Copper Ionophores as Antimicrobials

The promise of copper ionophores as antimicrobials rests on raising intracellular copper to disable core enzymes, restore antibiotic activity, and boost host killing, with clear microbial markers to track response.

2025-09-06

Zinc in Human Health and Infectious Diseases

This review maps zinc in human health and infectious diseases, linking host zinc control to pathogen survival, clinical trial signals, and simple gene and protein markers that explain microbiome shifts under zinc pressure.

2025-09-06

Current Biomedical Use of Copper Chelation Therapy

Current biomedical use of copper chelation therapy spans Wilson’s disease, cancer, lung fibrosis, diabetes, and neurodegeneration, with strongest support in Wilson’s disease and emerging roles in oncology and fibrosis, while neuro data remain limited.

2025-09-05

Undiagnosed Wilson’s Disease and Fibromyalgia Masking Bowel Perforation

This case study highlights the difficulty of diagnosing Wilson’s disease in a patient with psychiatric and gastrointestinal symptoms. It underscores the importance of considering Wilson’s disease when unexplained liver dysfunction and neurological symptoms are present, advocating for comprehensive diagnostic approaches.

2025-09-05

Influence of toxic metal exposure on the gut microbiota (Review)

This study investigates how copper supplementation affects gut microbiota and E. coli resistance in weaned piglets. It reveals that copper alters microbial composition and promotes antibiotic resistance, with potential implications for public health and animal agriculture.